These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25546799)

  • 21. Immunoglobulin replacement therapy by slow subcutaneous infusion.
    Berger M; Cupps TR; Fauci AS
    Ann Intern Med; 1980 Jul; 93(1):55-6. PubMed ID: 7396316
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence of infection is inversely related to steady-state (trough) serum IgG level in studies of subcutaneous IgG in PIDD.
    Berger M
    J Clin Immunol; 2011 Oct; 31(5):924-6. PubMed ID: 21643892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New choices for treatment with subcutaneous immunoglobulins.
    Pleguezuelo DE; Sánchez-Ramón S
    Med Clin (Barc); 2017 Jan; 148(2):86-90. PubMed ID: 27919413
    [No Abstract]   [Full Text] [Related]  

  • 24. 7th International Immunoglobulin Conference: Immunodeficiencies.
    Schmidt RE; Ochs HD
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):21. PubMed ID: 25546748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin therapy: methods of delivery.
    Ballow M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1038-9. PubMed ID: 18804269
    [No Abstract]   [Full Text] [Related]  

  • 26. [Substitution therapy in immunologic deficiency syndromes].
    Iartsev MN; Gomes LA
    Pediatriia; 1989; (12):71-6. PubMed ID: 2628915
    [No Abstract]   [Full Text] [Related]  

  • 27. Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysis.
    Shapiro RS
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):51-5. PubMed ID: 23806460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin deficiency syndromes and therapy.
    Huston DP; Kavanaugh AF; Rohane PW; Huston MM
    J Allergy Clin Immunol; 1991 Jan; 87(1 Pt 1):1-17. PubMed ID: 1704022
    [No Abstract]   [Full Text] [Related]  

  • 29. The ratio of mean daily IgG increment/mean daily dose in immunoglobulin replacement therapy in primary antibody deficiencies.
    Lucas M; Lee M; Oksenhendler E; Chapel H
    J Allergy Clin Immunol Pract; 2015; 3(6):998-1000.e2. PubMed ID: 26246125
    [No Abstract]   [Full Text] [Related]  

  • 30. Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency.
    Berger M
    Immunol Allergy Clin North Am; 2008 May; 28(2):413-37, x. PubMed ID: 18424340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Case of severe immunologic deficiency treated with transfer factor].
    Severi F; Ugazio AG; Colombo A
    Minerva Pediatr; 1974 Mar; 26(9):476-9. PubMed ID: 4840561
    [No Abstract]   [Full Text] [Related]  

  • 32. Subcutaneous immunoglobulin for patients with antibody deficiency.
    Helbert M; Farragher A
    Br J Hosp Med (Lond); 2007 Apr; 68(4):206-10. PubMed ID: 17465102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases.
    Stein MR; Koterba A; Rodden L; Berger M
    Postgrad Med; 2011 Sep; 123(5):186-93. PubMed ID: 21904101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin G subclass determination in diagnosis and management of antibody deficiency syndromes.
    Berger M
    J Pediatr; 1987 Feb; 110(2):325-8. PubMed ID: 3492598
    [No Abstract]   [Full Text] [Related]  

  • 35. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies.
    Dams ET; van der Meer JW
    Lancet; 1995 Apr; 345(8953):864. PubMed ID: 7898254
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG.
    Chua I; Lagos M; Charalambous BM; Workman S; Chee R; Grimbacher B
    J Allergy Clin Immunol; 2011 Jun; 127(6):1410-1. PubMed ID: 21376379
    [No Abstract]   [Full Text] [Related]  

  • 37. [Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
    Pac M
    Pol Merkur Lekarski; 2011 Jun; 30(180):413-6. PubMed ID: 21751550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The assessment and management of primary antibody deficiency.
    Empson M; Sinclair J; O'Donnell J; Ameratunga R; Fitzharris P; Steele R;
    N Z Med J; 2004 Jun; 117(1195):U914. PubMed ID: 15282626
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous immunoglobulin therapy for antibody deficiency.
    Nolte MT; Pirofsky B; Gerritz GA; Golding B
    Clin Exp Immunol; 1979 May; 36(2):237-43. PubMed ID: 477026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody mediated immunity: diagnosis and treatment of deficiency syndromes.
    Rich KC
    Compr Ther; 1979 Jun; 5(6):62-8. PubMed ID: 455936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.